|
Volumn 244, Issue 1-2, 2000, Pages 59-67
|
Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis
|
Author keywords
CD8+ T cells; ELISPOT; Melanoma vaccine; Peptide; T cell epitope
|
Indexed keywords
EPITOPE;
HLA A ANTIGEN;
MELANOMA VACCINE;
PEPTIDE;
CANCER VACCINE;
HLA A11;
HLA A3 ANTIGEN;
HLA ANTIGEN;
HLA B7 ANTIGEN;
HLA-A11;
MAGEA3 PROTEIN, HUMAN;
MART1 ANTIGEN;
MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100;
MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100;
MEMBRANE PROTEIN;
MONOPHENOL MONOOXYGENASE;
PEPTIDE FRAGMENT;
POLYVALENT MELANOMA CELL VACCINE;
TUMOR ANTIGEN;
TUMOR PROTEIN;
ARTICLE;
BINDING AFFINITY;
CLINICAL ARTICLE;
HUMAN;
IMMUNE RESPONSE;
IMMUNIZATION;
IMMUNOGENICITY;
MELANOMA;
PRIORITY JOURNAL;
T LYMPHOCYTE;
VACCINATION;
ADOPTIVE IMMUNOTHERAPY;
ALLELE;
ANTIGEN PRESENTATION;
CD8+ T LYMPHOCYTE;
GENETICS;
IMMUNOLOGY;
ALLELES;
ANTIGEN PRESENTATION;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
CD8-POSITIVE T-LYMPHOCYTES;
EPITOPES, T-LYMPHOCYTE;
HLA ANTIGENS;
HLA-A ANTIGENS;
HLA-A3 ANTIGEN;
HLA-B7 ANTIGEN;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
MELANOMA;
MEMBRANE GLYCOPROTEINS;
MONOPHENOL MONOOXYGENASE;
NEOPLASM PROTEINS;
PEPTIDE FRAGMENTS;
|
EID: 0034692682
PISSN: 00221759
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-1759(00)00254-4 Document Type: Article |
Times cited : (24)
|
References (22)
|